Navigation Links
ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
Date:7/29/2009

31, 2008. The six month increase is primarily the result of net sales, offset by our repurchase of $45 million principal amount of our senior convertible notes. Cash flow provided by operating activities for the six months ended June 30, 2009 was $15.9 million.

Looking ahead in 2009

ViroPharma is revising its guidance for the year 2009. The following guidance provided by ViroPharma are projections, based upon numerous assumptions, all of which are subject to certain risks and uncertainties. For a discussion of the risks and uncertainties associated with these forward looking statements, please see the Disclosure Notice below.

For the year 2009, ViroPharma expects the following:

  • Net Cinryze sales are expected to be $80 to $95 million.

  • Research and development (R&D) and selling, general and administrative (SG&A) expenses, including the impact of SFAS 123R, are expected to be $135 to $145 million, which includes approximately $18 million of maribavir-related expenses. SFAS 123R expenses are expected to be between $11 and $13 million.

The company is providing Cinryze net sales guidance and withdrawing Vancocin net sales guidance to align the company's guidance with its growth driver and in light of the August 4, 2009 FDA advisory committee regarding proposed bioequivalence recommendations for Vancocin.

Conference Call and Webcast

ViroPharma is hosting a live teleconference and webcast with senior management to discuss the financial announcement, guidance, and other business results on July 29, 2009 at 9:00 a.m. Eastern Time. To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international). After placing the call, please tell the operator you wish
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
2. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
3. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
4. ViroPharma to Present at Two May Healthcare Conferences
5. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
6. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
7. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
8. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
9. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
10. ViroPharma Provides Update on Vancocin(R)
11. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 The Florida Council ... Health Coalition, Group Victory, Miami Area Geriatric Education Center, ... of Broward County Commission on Substance Abuse, will hold ... May 12-14, at the Riverside Hotel. , This important ... education for everyone as well as clinical training for ...
(Date:5/6/2015)... york, NY (PRWEB) May 06, 2015 ... strategy, design, creative and technology, announced today that its ... expert advisor by Shocase, a marketing professional network aimed ... marketing sector. , Widely regarded as a specialist in ... the most high-profile branding programs over the last three ...
(Date:5/6/2015)... In celebration of their twentieth anniversary, Premierlacewigs.com launched ... away a deluxe human hair lace wig valued at $300 ... on a third-party giveaway tool. The important thing is the ... winner. , The hair is a crown, a reflection of ... a jewel for the past 20 years. Whether it is ...
(Date:5/6/2015)... May 06, 2015 Most people in the ... nursing or other care after age 65. But less than ... for it or even talking about it, reports the May ... people risk two problems. One is losing control over the ... families," says Dr. David Grabowski, a professor of health care ...
(Date:5/6/2015)... 06, 2015 Doctors who have done ... they are calling “unprecedented” tumor control in mesothelioma patients. ... new research. Click here to read it now. ... 25 mesothelioma patients between March and December 2014. They ... , “Pembrolizumab… provides robust antitumor activity in patients with ...
Breaking Medicine News(10 mins):Health News:Conference on Problem Gambling to be held in Ft. Lauderdale, FL 2Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2Health News:PremierLaceWigs.com Human Hair Lace Wigs Giveaway Could Change Your Hairstyle 2Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Researchers Say “Unprecedented” Mesothelioma Response Possible with Skin Cancer Drug, According to Surviving Mesothelioma 2
... Scientists at Warwick Medical School have uncovered the molecular ... ,health checkpoint, with cells that carry unequal numbers of ... , Studying simple yeast cells, scientists now understand the ... the correct number of chromosomes. , Most ...
... State University will lead a four-year, $5 million expanded ... discover proteins, or biomarkers, to help predict cardiovascular disease ... type 2 diabetes. Nearly 26 million Americans have ... U.S. The disease is a major cause of heart ...
... , TUESDAY, Nov. 1 (HealthDay News) -- Multiple sclerosis ... aim at the abnormal behavior of a specific type of ... the cells in question -- known as "B cells" -- ... and disabling nervous system disease, commonly called MS. The ...
... high school students are considered overweight, and while a myriad ... parents can do to help curb these rates, very little ... lose weight. Research led by public health doctoral candidate ... Philadelphia report wanting to lose weight, their actions are more ...
... an eight hour shift leads to substantial cost savings and energy ... Journal of the American College of Radiology . ... the use of computers and scanning equipment. "We should ... this equipment and look for ways to reduce it, both as ...
... NYU Langone Medical Center identified for the first time that ... outer and inner layers of the brain, called "blurring", may ... development of new therapies for degenerative brain conditions, such as ... issue of the Journal of Neuroscience . ...
Cached Medicine News:Health News:Warwick scientists discover how daughter cells receive the same number of chromosomes 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 2Health News:ASU leads $5 million NIH-sponsored research initiative to advance diabetes care and treatment 3Health News:New Multiple Sclerosis Therapy Promising in Early Trial 2Health News:New Multiple Sclerosis Therapy Promising in Early Trial 3Health News:Study finds overweight teens want to lose weight, going about it the wrong way 2Health News:Neurologists identify potential biomarker of cognitive decline for earlier diagnosis of disease 2
(Date:5/6/2015)... SAN FRANCISCO , May 6, 2015 /PRNewswire/ ... (MZEI:OB, MZEI:QB), manufacturers of the AsepticSure® Hospital Disinfection ... indicators used to confirm medical instrument sterilization in ...   absolute bactericidal kill for hospital room disinfection. ... process indicators that can directly monitor the lethality ...
(Date:5/6/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... and device innovation center in Cambridge, Massachusetts ... attract top scientists and bioengineers, as well as enhance ... Lilly Cambridge Innovation Center, a makerspace located in Kendall ... to explore how emerging technologies and connectivity can advance ...
(Date:5/6/2015)... , May 6, 2015   Sigma-Aldrich Corporation (NASDAQ: ... technology company, today announced a $50,000 product donation to ... initiative to replicate key findings from recent high-impact papers ... a collaboration between the online research marketplace Science ... and the open-access journal eLife. The ...
Breaking Medicine Technology:Hospital Rooms Cleaned to Autoclave Standards 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 2Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts 3Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... BURLINGTON, Vt., Feb. 6, 2012  After only three years ... Award from the International Society for Optics and Photonics ... products in the category of  "Life Sciences and Biophotonics." ... a patent-pending, innovative, high-intensity and exceptionally stable new light ...
... Pharmaceuticals, Inc. (NASDAQ: CADX ), a biopharmaceutical ... principally for use in the hospital setting, announced today ... (acetaminophen) injection. Cadence has notified the U.S. Food and ... recall of OFIRMEV lot number V005710 was initiated due ...
Cached Medicine Technology:89 North Wins Prestigious International Award 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 2Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 3Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection 4
Illuminated Phoroptor Refracting Instrument. Illumination is provided by a cool-running, energy efficient LEDs (Light Emitting Diodes) that light only what you need to see without affecting the darke...
Occluder and Maddox Rod...
Graham Field 10' Reversed Snellen Eye Chart....
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
Medicine Products: